30.04
Stoke Therapeutics Inc (STOK) 最新ニュース
Live market analysis of Stoke Therapeutics Inc.Insider Selling & Weekly Return Optimization Plans - newser.com
Does Stoke Therapeutics Inc. show high probability of rebound2025 Volume Leaders & Technical Analysis for Trade Confirmation - newser.com
Stoke Therapeutics, Inc. (NASDAQ:STOK) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Stoke Therapeutics Shares Plunge Following Clinical Trial Data Release - AD HOC NEWS
Stoke Therapeutics (NASDAQ:STOK) Stock Price Down 6.3%Should You Sell? - MarketBeat
Will Stoke Therapeutics Inc. stock maintain momentum in 2025Weekly Profit Recap & Precise Swing Trade Entry Alerts - newser.com
Is Stoke Therapeutics Inc. stock a good choice for value investorsTrade Entry Report & Short-Term Trading Opportunity Alerts - newser.com
What insider trading reveals about Stoke Therapeutics Inc. stockTrade Risk Assessment & Daily Technical Forecast Reports - newser.com
Stoke Therapeutics Inc expected to post a loss of 57 cents a shareEarnings Preview - TradingView
Exit strategy if you’re trapped in Stoke Therapeutics Inc.July 2025 Macro Moves & Weekly High Return Opportunities - newser.com
Stoke Therapeutics, Inc. (STOK) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
Total debt per share of Stoke Therapeutics, Inc. – BER:0GT - TradingView
Stoke Therapeutics to Host Webcast and Conference Call to Discuss Third Quarter 2025 Business and Financial Updates - Business Wire
Stoke Therapeutics (STOK) Price Target Increased by 16.51% to 28.79 - Nasdaq
Stoke Therapeutics (STOK) Projected to Post Earnings on Tuesday - MarketBeat
Will Stoke Therapeutics Inc. stock maintain dividend yieldExit Point & AI Forecast for Swing Trade Picks - Fundação Cultural do Pará
Why Stoke Therapeutics Inc. stock is popular among millennialsTrade Performance Summary & Stock Market Timing Techniques - fcp.pa.gov.br
Take Profit: Is Stoke Therapeutics Inc. stock a good choice for value investorsTrade Risk Summary & Target Return Focused Stock Picks - fcp.pa.gov.br
Dravet Syndrome Pipeline 2025: Key Developments, Emerging - openPR.com
How Stoke Therapeutics Inc. stock trades before earningsDividend Hike & Step-by-Step Swing Trade Plans - Fundação Cultural do Pará
Weiss Ratings Reaffirms Sell (D+) Rating for Stoke Therapeutics (NASDAQ:STOK) - MarketBeat
大文字化:
|
ボリューム (24 時間):